Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Ted Jenkins - VP, IR Ankit Mahadevia - Co-Founder, CEO, President & Director David Melnick - Chief Medical Officer Cristina Larkin - COO Satyavrat Shukla - CFO Conference Call Participants Lyla Youssef - Cowen and Company Louise Chen - Cantor Fitzgerald & Co. Kevin DeGeeter - Oppenheimer Esther Hong - Berenberg Raghuram Selvaraju - H.C. Wainwright & Co. Operator Good day, everyone, and than ...